Moringa oleifera Lam. is a traditionally used medicinal plant belonging to the Moringaceae family. It is widely distributed in tropical and subtropical regions, such as the Indian subcontinent, sub-Saharan Africa, and Southeast Asia. In folk medicine, it is used for its nutritional, antipyretic, and anti-inflammatory properties. Numerous pharmacological studies have documented its antioxidant activity, hypotensive effects, and potential role as a hypoglycemic agent, attributable to its rich composition of bioactive compounds, including polyphenols, flavonoids, and tannins. The objective of this experimental project was to conduct an in vitro study of extracts of M. oleifera Lam. to evaluate their potential use in the prevention of diabetes mellitus and in reducing the oxidative damage associated with this disease. Two extracts were studied: one aqueous and the other ethanolic, both obtained from the leaves of M. oleifera. The TPC (Total Phenolic Content) assay was used to determine the total phenolic content, while the TFC (Total Flavonoid Content) assay was used to quantify the presence of flavonoids in the extracts. Antioxidant capacity was assessed using the ORAC (Oxygen Radical Absorbance Capacity) assay, which provides a quantitative determination. To evaluate hypoglycemic activity, the α-glucosidase inhibition assay was used; α-glucosidase is a key enzyme in intestinal carbohydrate metabolism: its inhibition, in fact, slows the hydrolysis of dietary oligosaccharides and reduces the postprandial glycemic peak. A preliminary analysis of the phytochemical composition was performed using HPLC-DAD analysis. The results obtained helped to further elucidate the antiglycemic properties and the antioxidant and phytotherapeutic potential of M. oleifera Lam. leaf extracts.
Moringa oleifera Lam. è una pianta medicinale di impiego tradizionale appartenente alla famiglia delle Moringaceae. È ampiamente distribuita nelle regioni tropicali e subtropicali, come subcontinente indiano, Africa subsahariana e Sud-Est asiatico. Nella medicina popolare viene impiegata per le sue proprietà nutritive, antipiretiche e antinfiammatorie. Numerosi studi farmacologici ne hanno documentato l’attività antiossidante, gli effetti ipotensivi e un potenziale ruolo come ipoglicemizzante, attribuibili alla ricca composizione in composti bioattivi, tra cui polifenoli, flavonoidi e tannini. Il presente progetto sperimentale si è posto come obiettivo lo studio in vitro di estratti di M. oleifera Lam., allo scopo di valutarne il potenziale impiego nella prevenzione del diabete mellito e nella riduzione del danno ossidativo associato a tale patologia. Sono stati studiati due estratti: uno acquoso e l’altro etanolico, entrambi ottenuti dalle foglie di M. oleifera. Per determinare il contenuto totale in composti fenolici è stato utilizzato il saggio TPC (Total Phenolic Content), mentre il saggio TFC (Total Flavonoid Content) ha permesso di quantificare la presenza di flavonoidi negli estratti. La capacità antiossidante è stata valutata mediante il saggio ORAC (Oxygen Radical Absorbance Capacity), che ne fornisce una determinazione quantitativa. Per la valutazione dell’attività ipoglicemizzante è stato impiegato il saggio di inibizione dell’α-glucosidasi, un enzima chiave nel metabolismo dei carboidrati intestinali: la sua inibizione, infatti, consente di rallentare l’idrolisi degli oligosaccaridi alimentari e di ridurre il picco glicemico postprandiale. Un’analisi preliminare della composizione fitochimica è stata effettuata mediante analisi HPLC-DAD. I risultati ottenuti hanno contribuito ad approfondire le caratteristiche antiglicemiche e il potenziale antiossidante e fitoterapico degli estratti di foglie di M. oleifera Lam.
Studio sperimentale di estratti di foglie di Moringa oleifera Lam.: attività antiossidante e inibizione dell'enzima α-glucosidasi
LAGO, ELISA
2025/2026
Abstract
Moringa oleifera Lam. is a traditionally used medicinal plant belonging to the Moringaceae family. It is widely distributed in tropical and subtropical regions, such as the Indian subcontinent, sub-Saharan Africa, and Southeast Asia. In folk medicine, it is used for its nutritional, antipyretic, and anti-inflammatory properties. Numerous pharmacological studies have documented its antioxidant activity, hypotensive effects, and potential role as a hypoglycemic agent, attributable to its rich composition of bioactive compounds, including polyphenols, flavonoids, and tannins. The objective of this experimental project was to conduct an in vitro study of extracts of M. oleifera Lam. to evaluate their potential use in the prevention of diabetes mellitus and in reducing the oxidative damage associated with this disease. Two extracts were studied: one aqueous and the other ethanolic, both obtained from the leaves of M. oleifera. The TPC (Total Phenolic Content) assay was used to determine the total phenolic content, while the TFC (Total Flavonoid Content) assay was used to quantify the presence of flavonoids in the extracts. Antioxidant capacity was assessed using the ORAC (Oxygen Radical Absorbance Capacity) assay, which provides a quantitative determination. To evaluate hypoglycemic activity, the α-glucosidase inhibition assay was used; α-glucosidase is a key enzyme in intestinal carbohydrate metabolism: its inhibition, in fact, slows the hydrolysis of dietary oligosaccharides and reduces the postprandial glycemic peak. A preliminary analysis of the phytochemical composition was performed using HPLC-DAD analysis. The results obtained helped to further elucidate the antiglycemic properties and the antioxidant and phytotherapeutic potential of M. oleifera Lam. leaf extracts.| File | Dimensione | Formato | |
|---|---|---|---|
|
Lago_Elisa.pdf
Accesso riservato
Dimensione
2.62 MB
Formato
Adobe PDF
|
2.62 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/117737